Stockreport

CytomX Therapeutics (CTMX) Is Up 29.1% After Promising CX-801 Phase 1 Biomarker Data Release [Yahoo! Finance]

CytomX Therapeutics, Inc.  (CTMX) 
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com
PDF tumor-selective activation of interferon signaling and immune response in patients who failed prior checkpoint inhibitors, presented at the SITC 2025 annual meeting. T [Read more]